Annual Total Liabilities
$58.19 B
-$673.52 M-1.14%
December 1, 2024
Summary
- As of February 7, 2025, GSK annual total liabilities is $58.19 billion, with the most recent change of -$673.52 million (-1.14%) on December 1, 2024.
- During the last 3 years, GSK annual total liabilities has fallen by -$19.76 billion (-25.35%).
- GSK annual total liabilities is now -28.38% below its all-time high of $81.26 billion, reached on December 31, 2020.
Performance
GSK Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$59.68 B
+$3.65 B+6.52%
September 30, 2024
Summary
- As of February 7, 2025, GSK quarterly total liabilities is $59.68 billion, with the most recent change of +$3.65 billion (+6.52%) on September 30, 2024.
- Over the past year, GSK quarterly total liabilities has increased by +$817.53 million (+1.39%).
- GSK quarterly total liabilities is now -32.25% below its all-time high of $88.09 billion, reached on March 31, 2022.
Performance
GSK Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
GSK Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -1.1% | +1.4% |
| 3 y3 years | -25.4% | -32.3% |
| 5 y5 years | -27.6% | -32.3% |
GSK Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -25.4% | at low | -32.3% | +6.5% |
| 5 y | 5-year | -28.4% | at low | -32.3% | +6.5% |
| alltime | all time | -28.4% | +8739.1% | -32.3% | +5446.6% |
GSK Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $58.19 B(-1.1%) | - |
| Sep 2024 | - | $59.68 B(+6.5%) |
| Jun 2024 | - | $56.03 B(-2.0%) |
| Mar 2024 | - | $57.17 B(-2.9%) |
| Dec 2023 | $58.87 B(-2.8%) | $58.87 B(+0.0%) |
| Sep 2023 | - | $58.86 B(-1.3%) |
| Jun 2023 | - | $59.66 B(+1.9%) |
| Mar 2023 | - | $58.56 B(-3.3%) |
| Dec 2022 | $60.57 B(-22.3%) | $60.57 B(+5.1%) |
| Sep 2022 | - | $57.62 B(-28.5%) |
| Jun 2022 | - | $80.54 B(-8.6%) |
| Mar 2022 | - | $88.09 B(+13.0%) |
| Dec 2021 | $77.96 B(-4.1%) | $77.96 B(+2.0%) |
| Sep 2021 | - | $76.45 B(-0.3%) |
| Jun 2021 | - | $76.72 B(-2.2%) |
| Mar 2021 | - | $78.44 B(-3.5%) |
| Dec 2020 | $81.26 B(+1.0%) | $81.26 B(+4.8%) |
| Sep 2020 | - | $77.57 B(-2.3%) |
| Jun 2020 | - | $79.40 B(-0.2%) |
| Mar 2020 | - | $79.52 B(-1.1%) |
| Dec 2019 | $80.42 B(+16.5%) | $80.42 B(+0.4%) |
| Sep 2019 | - | $80.13 B(+4.2%) |
| Jun 2019 | - | $76.88 B(-0.1%) |
| Mar 2019 | - | $76.95 B(+11.5%) |
| Dec 2018 | $69.02 B(-3.4%) | $69.02 B(-3.5%) |
| Sep 2018 | - | $71.50 B(+0.1%) |
| Jun 2018 | - | $71.40 B(-3.1%) |
| Mar 2018 | - | $73.68 B(+3.1%) |
| Dec 2017 | $71.48 B(+7.5%) | $71.48 B(-1.3%) |
| Sep 2017 | - | $72.46 B(+3.5%) |
| Jun 2017 | - | $70.01 B(+4.6%) |
| Mar 2017 | - | $66.93 B(+0.7%) |
| Dec 2016 | $66.48 B(+0.7%) | $66.48 B(-6.4%) |
| Sep 2016 | - | $71.02 B(-1.2%) |
| Jun 2016 | - | $71.89 B(+4.3%) |
| Mar 2016 | - | $68.89 B(+4.3%) |
| Dec 2015 | $66.03 B(+18.8%) | $66.03 B(-0.5%) |
| Sep 2015 | - | $66.36 B(-3.1%) |
| Jun 2015 | - | $68.51 B(-0.7%) |
| Mar 2015 | - | $68.99 B(+24.1%) |
| Dec 2014 | $55.59 B(-1.6%) | $55.59 B(-0.9%) |
| Sep 2014 | - | $56.12 B(+2.9%) |
| Jun 2014 | - | $54.53 B(+1.5%) |
| Mar 2014 | - | $53.72 B(-4.9%) |
| Dec 2013 | $56.52 B(+0.7%) | $56.52 B(+1.9%) |
| Sep 2013 | - | $55.46 B(+4.5%) |
| Jun 2013 | - | $53.07 B(-1.0%) |
| Mar 2013 | - | $53.60 B(-4.5%) |
| Dec 2012 | $56.15 B(+13.0%) | $56.15 B(+3.5%) |
| Sep 2012 | - | $54.25 B(+0.9%) |
| Jun 2012 | - | $53.78 B(+7.9%) |
| Mar 2012 | - | $49.82 B(+0.3%) |
| Dec 2011 | $49.70 B(-0.9%) | $49.70 B(-4.0%) |
| Sep 2011 | - | $51.74 B(-1.4%) |
| Jun 2011 | - | $52.47 B(-0.1%) |
| Mar 2011 | - | $52.53 B(+4.8%) |
| Dec 2010 | $50.14 B(-3.5%) | $50.14 B(-0.9%) |
| Sep 2010 | - | $50.59 B(+1.0%) |
| Jun 2010 | - | $50.07 B(-0.4%) |
| Mar 2010 | - | $50.29 B(-3.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2009 | $51.94 B(+14.1%) | $51.94 B(+2.1%) |
| Sep 2009 | - | $50.90 B(+10.7%) |
| Jun 2009 | - | $45.98 B(+4.3%) |
| Mar 2009 | - | $44.09 B(-3.1%) |
| Dec 2008 | $45.52 B(+8.5%) | $45.52 B(-2.0%) |
| Sep 2008 | - | $46.43 B(-6.1%) |
| Jun 2008 | - | $49.45 B(+17.9%) |
| Mar 2008 | - | $41.95 B(+0.0%) |
| Dec 2007 | $41.94 B(+34.7%) | $41.94 B(+17.2%) |
| Sep 2007 | - | $35.80 B(+12.9%) |
| Jun 2007 | - | $31.70 B(-0.6%) |
| Mar 2007 | - | $31.90 B(+2.5%) |
| Dec 2006 | $31.14 B(-7.7%) | $31.14 B(+1.1%) |
| Sep 2006 | - | $30.79 B(-4.5%) |
| Jun 2006 | - | $32.26 B(-1.9%) |
| Mar 2006 | - | $32.87 B(-2.6%) |
| Dec 2005 | $33.75 B(+6.6%) | $33.75 B(-0.9%) |
| Sep 2005 | - | $34.05 B(+0.9%) |
| Jun 2005 | - | $33.75 B(+3.4%) |
| Mar 2005 | - | $32.64 B(+3.1%) |
| Dec 2004 | $31.65 B(+14.3%) | $31.65 B(+25.8%) |
| Sep 2004 | - | $25.16 B(+2.0%) |
| Jun 2004 | - | $24.66 B(-17.5%) |
| Mar 2004 | - | $29.89 B(+7.9%) |
| Dec 2003 | $27.70 B(+15.0%) | $27.70 B(+7.2%) |
| Sep 2003 | - | $25.85 B(+3.1%) |
| Jun 2003 | - | $25.06 B(+8.3%) |
| Mar 2003 | - | $23.15 B(-3.9%) |
| Dec 2002 | $24.08 B(+22.6%) | $24.08 B(+6.4%) |
| Sep 2002 | - | $22.63 B(-1.4%) |
| Jun 2002 | - | $22.94 B(+10.4%) |
| Mar 2002 | - | $20.78 B(+5.7%) |
| Dec 2001 | $19.65 B(+4.3%) | $19.65 B(+2.1%) |
| Sep 2001 | - | $19.25 B(+6.2%) |
| Jun 2001 | - | $18.12 B(-8.2%) |
| Mar 2001 | - | $19.75 B(+4.8%) |
| Dec 2000 | $18.84 B(+61.2%) | $18.84 B(+2.1%) |
| Sep 2000 | - | $18.45 B(-2.8%) |
| Jun 2000 | - | $18.99 B(-1.9%) |
| Mar 2000 | - | $19.36 B(+65.6%) |
| Dec 1999 | $11.69 B(+7.4%) | $11.69 B(+8.8%) |
| Jun 1999 | - | $10.74 B(-1.2%) |
| Dec 1998 | $10.88 B(+0.3%) | $10.88 B(+5.3%) |
| Jun 1998 | - | $10.33 B(-4.7%) |
| Dec 1997 | $10.84 B(-9.5%) | $10.84 B(-9.5%) |
| Dec 1996 | $11.98 B(-7.2%) | $11.98 B(-0.2%) |
| Dec 1995 | $12.91 B(+7.5%) | - |
| Jun 1995 | - | $12.01 B(+184.7%) |
| Jun 1995 | $12.01 B(+184.7%) | - |
| Jun 1994 | $4.22 B(-0.2%) | $4.22 B(-0.2%) |
| Jun 1993 | $4.23 B(+8.9%) | $4.23 B(+8.9%) |
| Jun 1992 | $3.88 B(-2.8%) | $3.88 B(-2.8%) |
| Jun 1991 | $3.99 B(+35.8%) | $3.99 B(+35.8%) |
| Jun 1990 | $2.94 B(+64.1%) | $2.94 B(+64.1%) |
| Jun 1989 | $1.79 B(-1.5%) | $1.79 B(-1.5%) |
| Jun 1988 | $1.82 B(+26.3%) | $1.82 B(+26.3%) |
| Jun 1987 | $1.44 B(+33.8%) | $1.44 B(+33.8%) |
| Jun 1986 | $1.08 B(+53.8%) | $1.08 B |
| Jun 1985 | $699.73 M(+6.3%) | - |
| Jun 1984 | $658.37 M | - |
FAQ
- What is GSK annual total liabilities?
- What is the all time high annual total liabilities for GSK?
- What is GSK annual total liabilities year-on-year change?
- What is GSK quarterly total liabilities?
- What is the all time high quarterly total liabilities for GSK?
- What is GSK quarterly total liabilities year-on-year change?
What is GSK annual total liabilities?
The current annual total liabilities of GSK is $58.19 B
What is the all time high annual total liabilities for GSK?
GSK all-time high annual total liabilities is $81.26 B
What is GSK annual total liabilities year-on-year change?
Over the past year, GSK annual total liabilities has changed by -$673.52 M (-1.14%)
What is GSK quarterly total liabilities?
The current quarterly total liabilities of GSK is $59.68 B
What is the all time high quarterly total liabilities for GSK?
GSK all-time high quarterly total liabilities is $88.09 B
What is GSK quarterly total liabilities year-on-year change?
Over the past year, GSK quarterly total liabilities has changed by +$817.53 M (+1.39%)